Recent research has provided new insights on the epidemiology, pathology and
immunology of canine leishmaniosis (CanL) and its genetic basis. The prevalence of …

Visceral Leishmaniasis (VL) is the most fatal form of disease leishmaniasis. To date, there
are no effective prophylactic measures and therapeutics available against VL. Recently, new …

Human visceral leishmaniasis (VL) and canine visceral leishmaniasis (CVL) are the most
important emerging diseases with high prevalence in Latin American countries and are …

Leishmaniasis remains a major public health problem worldwide and is classified as
Category I by the TDR/WHO, mainly due to the absence of control. Many experimental …

Human vaccination against leishmaniasis using live Leishmania was used in Middle East
and Russia (1941–1980). First-generation vaccines, composed by killed parasites induce …

Canine leishmaniosis (CanL) is a vector-borne disease caused by the protozoan
Leishmania (Leishmania) infantum species [syn. L.(L.) infantum chagasi species in the …

In this study, we investigated in dogs the immunogenicity and protective immunity against
Leishmania (Leishmania) chagasi infection induced by vaccination with a formulation …

Canine leishmaniosis (CanL) is caused by the parasite Leishmania infantum and is a
systemic disease, which can present with variable clinical signs, and clinicopathological …

Canine leishmaniosis caused by Leishmania infantum (Syn. L. chagasi) is an important
zoonosis with a complex pathogenesis. Parasite transmission occurs via female sandflies …

The control of infection by Leishmania infantum (syn. Leishmania chagasi) in dogs is
essential to stop the current spread of zoonotic visceral leishmaniasis. The past few years …